Direktorat Registrasi ObatValid

AMPICILLIN SODIUM/SULBACTAM SODIUM

Claim this product
BPOM Number
GKL2517634944A1
Approved
18 November 2025
Expiry
17 November 2030
Form
SERBUK INJEKSI

About This Registration

AMPICILLIN SODIUM/SULBACTAM SODIUM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2517634944A1. Its current registration status is Valid, with the licence valid until 17 November 2030. The product is registered to INTERBAT - INDONESIA. BPOM first approved this registration in November 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, ISI 10 VIAL @ 750 MG
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (2)

AMPICILLIN SODIUM AND SULBACTAM SODIUM ~ AMPICILLIN 500 MG &SULBACTAM 250 MG

Market Intelligence

Owner Portfolio
INTERBAT - INDONESIA holds 329 BPOM registrations
Manufacturer Scale
INTERBAT - INDONESIA produces 329 registered products
Registration Age
Registered for 7 months

FDA Cross-Reference

via openFDA
Generic Name
AMPICILLIN SODIUM AND SULBACTAM SODIUM
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAMUSCULAR

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1